[Original Articles]]

1.Ono M, Haratake M, Nakayama M, Kaneko Y, Kawabata K, Mori H, P. Kung M, F. Kung H,
Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives asamyloid imaging agents for Alzheimer’s disease.
Nuclear Medicine and Biology. 32( 4):329-335 (2005)

2.Haratake M, Fukunaga M, Ono M, Nakayama M,
Synthesis of vanadium(IV,V) hydroxamic acid complexes and in vivo assessment of their insulin-like activity.
Jouranal of Biological Inorganic Chemistry. 10(3):250-258 (2005) 

3.Haratake M, Fujimoto K, Ono M, Nakayama M,
Selenium binding to human hemoglobin via selenotrisulfide.
Biochimica et Biophysica Acta- General Subjects.1723(1-3):215-220 (2005)

4. Ogawa K, Mukai T, Arano Y, Ono M, Hanaoka H, Ishino S, Hashimoto K, Nishimura H, Saji H,
Development of a rhenium-186-labeled MAG3-conjugatedbisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals.
Bioconjugate Chemistry.16(4):751-757(2005)

5.Ono M, Yoshida N, Ishibashi K, Haratake M, Arano Y, Mori H, Nakayama M,
Radioiodinated flavones for in vivo imaging of β-amyloid plaques in the brain.
Journal of Medicinal Chemistry. 48(23):7253-7260 (2005)

6.Haratake M, Yasumoto K, Ono M, Akashi M, Nakayama M,
Synthesis of hydrophilic macroporous chelating polymers and their versatility in the preconcentration of metals in seawater samples.
Analytica Chimica Acta. 561(1-2):183-190 (2006)